USP11 regulates PML stability to control Notch-induced malignancy in brain tumours.
Nat Commun
; 5: 3214, 2014.
Article
in En
| MEDLINE
| ID: mdl-24487962
ABSTRACT
The promyelocytic leukaemia (PML) protein controls multiple tumour suppressive functions and is downregulated in diverse types of human cancers through incompletely characterized post-translational mechanisms. Here we identify USP11 as a PML regulator by RNAi screening. USP11 deubiquitinates and stabilizes PML, thereby counteracting the functions of PML ubiquitin ligases RNF4 and the KLHL20-Cul3 (Cullin 3)-Roc1 complex. We find that USP11 is transcriptionally repressed through a Notch/Hey1-dependent mechanism, leading to PML destabilization. In human glioma, Hey1 upregulation correlates with USP11 and PML downregulation and with high-grade malignancy. The Notch/Hey1-induced downregulation of USP11 and PML not only confers multiple malignant characteristics of aggressive glioma, including proliferation, invasiveness and tumour growth in an orthotopic mouse model, but also potentiates self-renewal, tumour-forming capacity and therapeutic resistance of patient-derived glioma-initiating cells. Our study uncovers a PML degradation mechanism through Notch/Hey1-induced repression of the PML deubiquitinase USP11 and suggests an important role for this pathway in brain tumour pathogenesis.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiolester Hydrolases
/
Transcription Factors
/
Brain Neoplasms
/
Nuclear Proteins
/
Glioblastoma
/
Cell Cycle Proteins
/
Tumor Suppressor Proteins
/
Basic Helix-Loop-Helix Transcription Factors
/
Receptors, Notch
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2014
Document type:
Article
Affiliation country: